| Title: |
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial |
| Authors: |
Dimopoulos, Meletios A, Trotman, Judith, Tedeschi, Alessandra, Matous, Jeffrey V, Macdonald, David, Tam, Constantine, Tournilhac, Olivier, Ma, Shuo, Oriol, Albert, Heffner, Leonard T, Shustik, Chaim, García-Sanz, Ramón, Cornell, Robert F, de Larrea, Carlos Fernández, Castillo, Jorge J, Granell, Miquel, Kyrtsonis, Marie-Christine, Leblond, Veronique, Symeonidis, Argiris, Kastritis, Efstathios, Singh, Priyanka, Li, Jianling, Graef, Thorsten, Bilotti, Elizabeth, Treon, Steven, Buske, Christian |
| Source: |
In The Lancet Oncology February 2017 18(2):241-250 |
| Database: |
ScienceDirect |
